• Two null mutations in trans: no reason to perform further tests on the responsiveness to BH4; treat with Phe-restricted diet. • Two responsive mutations: treat the patient with sapropterin. • One responsive mutation or unknown genotype: consider further tests for BH4 responsiveness. • If the genotype is not identified, further tests of BH4 responsiveness should be considered. |